VERIGRAFT is part of a new EU-funded project to develop an advanced TELEGRAFT blood vessel for safe hemodialysis.

VERIGRAFT has received a grant through the EU Horizon Europe Framework Program for participation in the TELEGRAFT project. Together with six other partners in the consortium, the project aims to generate an arteriovenous graft (AVG) that is puncture safe, anti-thrombotic, has drug releasing abilities, and is equipped with sensors for remote monitoring of blood pressure, blood flow, tissue integrity, and infection. Over 10% of the population worldwide is affected by chronic kidney disease and most of the patients are relying on hemodialysis to survive. 70% of the arteriovenous grafts currently used for hemodialysis fail within a year due to occlusion, thrombosis, or infection. The TELEGRAFT AVG will be a more advanced and reliable alternative to the AVGs currently available for hemodialysis. Total grant amount 4 352 522.00 Euro.

For more information, visit the TELEGRAFT project web page:

https://www.sdu.dk/en/forskning/telegraft